D-0295-2026 Class II Ongoing

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0295-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Dec 30, 2025 and is designated Class II. Reason for recall: Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules The recall status is ongoing. Affected quantity: 22,896 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 28, 2026
Initiation Date
Dec 30, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,896 bottles

Product description

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Reason for recall

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Distribution pattern

US Nationwide.

Code information

Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0295-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0295-2026. Report a data issue: hello@regdatalab.com.